textabstractBackground: Reliable population-based incidence and survival data on extracutaneous melanoma (ECM) are sparse. Methods: Incidence data (1989-2006) from the Netherlands Cancer Registry were combined with vital status on January 1, 2008. Age-adjusted annual incidence rates were calculated by direct standardization, and the estimated annual percentage change was estimated to detect changing trends in incidence. Additionally, we carried out cohort-based relative survival analysis. Results: Ocular melanomas were the most common ECM subsite with European standardized incidence rates (ESR) of 10.7 and 8.2 per 1,000,000 person-years for males and females, respectively. In comparison, for cutaneous melanoma (CM), the ESRs for men and wom...
OBJECTIVE: To describe trends in incidence, treatment and survival of patients with basal cell carci...
International audiencePURPOSE: To estimate incidence rates of uveal melanoma in Europe from 1983 to ...
We analysed trends in incidence for in situ and invasive melanoma in some European countries during ...
BACKGROUND: Reliable population-based incidence and survival data on extracutaneous melanoma (ECM) a...
textabstractAbstract: Background: It has been debated that the epidemic of melanoma is largely due...
textabstractBackground: We present survival outcomes of patients registered in the Dutch population-...
Background Cutaneous melanoma (CM) is a multifactorial disease, with both environmental and genetic ...
Epidemiology of rare cutaneous malignancies in the general population is poorly documented. This des...
Background: Melanoma is rare in the first two decades of life. Trends in incidence differ across cou...
textabstractEpidemiology of rare cutaneous malignancies in the general population is poorly document...
Increases in cutaneous malignant melanoma (CMM) incidence and mortality rates have occurred in the l...
Epidemiology of rare cutaneous malignancies in the general population is poorly documented. This des...
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northw...
Purpose: The purpose of this study was to examine why Norway has the highest rate of mortality due t...
BACKGROUND: Melanoma incidence has increased rapidly in the last decades, and predictions show a con...
OBJECTIVE: To describe trends in incidence, treatment and survival of patients with basal cell carci...
International audiencePURPOSE: To estimate incidence rates of uveal melanoma in Europe from 1983 to ...
We analysed trends in incidence for in situ and invasive melanoma in some European countries during ...
BACKGROUND: Reliable population-based incidence and survival data on extracutaneous melanoma (ECM) a...
textabstractAbstract: Background: It has been debated that the epidemic of melanoma is largely due...
textabstractBackground: We present survival outcomes of patients registered in the Dutch population-...
Background Cutaneous melanoma (CM) is a multifactorial disease, with both environmental and genetic ...
Epidemiology of rare cutaneous malignancies in the general population is poorly documented. This des...
Background: Melanoma is rare in the first two decades of life. Trends in incidence differ across cou...
textabstractEpidemiology of rare cutaneous malignancies in the general population is poorly document...
Increases in cutaneous malignant melanoma (CMM) incidence and mortality rates have occurred in the l...
Epidemiology of rare cutaneous malignancies in the general population is poorly documented. This des...
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northw...
Purpose: The purpose of this study was to examine why Norway has the highest rate of mortality due t...
BACKGROUND: Melanoma incidence has increased rapidly in the last decades, and predictions show a con...
OBJECTIVE: To describe trends in incidence, treatment and survival of patients with basal cell carci...
International audiencePURPOSE: To estimate incidence rates of uveal melanoma in Europe from 1983 to ...
We analysed trends in incidence for in situ and invasive melanoma in some European countries during ...